Therefore, these findings further suggest that RHBDL2 may be a crucial regulator of the spontaneous conversion of CD44-/CD24- TNBC cells into CD44+/CD24- CSCs by enhancing the YAP1/USP31/NF-κB signaling in breast cancer cells. Here, RHBDL2 is linked to breast cancer.